Ribomic Overview

  • Founded
  • 2003
Founded
  • Status
  • Public
  • Employees
  • 25
Employees
  • Stock Symbol
  • 4591
Stock Symbol
  • Share Price
  • $2.76
  • (As of Tuesday Closing)

Ribomic General Information

Description

Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.

Contact Information

Website
www.ribomic.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
TKS
Primary Office
  • Shirokanedai Usui Building 6th Floor
  • 3-16-13 Shirokanedai
  • Tokyo, Minato-ku 108-0071
  • Japan
+81 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ribomic Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.76 $2.79 $2.69 - $6.69 $77M 27.9M 289K -$0.44

Ribomic Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 29,947 29,947 30,223 71,626
Revenue 867 867 1,116 72
EBITDA (10,935) (10,935) (7,699) (7,294)
Net Income (11,196) (11,196) (7,864) (7,546)
Total Assets 55,474 55,474 21,002 23,170
Total Debt 0 0 0 9,019
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ribomic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ribomic‘s full profile, request access.

Request a free trial

Ribomic Executive Team (1)

Name Title Board Seat Contact Info
Yoshikazu Nakamura Ph.D Founder, President & Chief Executive Officer
To view Ribomic’s complete executive team members history, request access »

Ribomic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ribomic Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ribomic‘s full profile, request access.

Request a free trial